[1-[2-[[3-(2,6-dioxopiperidin-3-yl)-2-methyl-4-oxoquinazolin-5-yl]amino]-2-oxoethyl]triazol-4-yl]methyl N-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]carbamate

C33H30N10O9 — CID 151626886

IUPAC[1-[2-[[3-(2,6-dioxopiperidin-3-yl)-2-methyl-4-oxoquinazolin-5-yl]amino]-2-oxoethyl]triazol-4-yl]methyl N-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]carbamate
SMILESCc1nc2cccc(NC(=O)Cn3cc(COC(=O)Nc4cccc5c4CN(C4CCC(=O)NC4=O)C5=O)nn3)c2c(=O)n1C1CCC(=O)NC1=O
InChIInChI=1S/C33H30N10O9/c1-16-34-21-6-3-7-22(28(21)32(50)43(16)24-9-11-26(45)38-30(24)48)35-27(46)14-41-12-17(39-40-41)15-52-33(51)36-20-5-2-4-18-19(20)13-42(31(18)49)23-8-10-25(44)37-29(23)47/h2-7,12,23-24H,8-11,13-15H2,1H3,(H,35,46)(H,36,51)(H,37,44,47)(H,38,45,48)
InChIKeyQPRMZOAFBVJXSC-UHFFFAOYSA-N
MW710.66 g/mol
LogP0.42
Rot. Bonds8

About [1-[2-[[3-(2,6-dioxopiperidin-3-yl)-2-methyl-4-oxoquinazolin-5-yl]amino]-2-oxoethyl]triazol-4-yl]methyl N-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]carbamate

[1-[2-[[3-(2,6-dioxopiperidin-3-yl)-2-methyl-4-oxoquinazolin-5-yl]amino]-2-oxoethyl]triazol-4-yl]methyl N-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]carbamate (PubChem CID 151626886) has the molecular formula C33H30N10O9 and a molecular weight of 710.66 g/mol. Its IUPAC name is [1-[2-[[3-(2,6-dioxopiperidin-3-yl)-2-methyl-4-oxoquinazolin-5-yl]amino]-2-oxoethyl]triazol-4-yl]methyl N-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]carbamate.

Molecular Properties

Compound Name[1-[2-[[3-(2,6-dioxopiperidin-3-yl)-2-methyl-4-oxoquinazolin-5-yl]amino]-2-oxoethyl]triazol-4-yl]methyl N-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]carbamate
PubChem CID151626886
Molecular FormulaC33H30N10O9
Molecular Weight710.66 g/mol
Exact Mass710.22
IUPAC Name[1-[2-[[3-(2,6-dioxopiperidin-3-yl)-2-methyl-4-oxoquinazolin-5-yl]amino]-2-oxoethyl]triazol-4-yl]methyl N-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]carbamate
SMILESCc1nc2cccc(NC(=O)Cn3cc(COC(=O)Nc4cccc5c4CN(C4CCC(=O)NC4=O)C5=O)nn3)c2c(=O)n1C1CCC(=O)NC1=O
InChIInChI=1S/C33H30N10O9/c1-16-34-21-6-3-7-22(28(21)32(50)43(16)24-9-11-26(45)38-30(24)48)35-27(46)14-41-12-17(39-40-41)15-52-33(51)36-20-5-2-4-18-19(20)13-42(31(18)49)23-8-10-25(44)37-29(23)47/h2-7,12,23-24H,8-11,13-15H2,1H3,(H,35,46)(H,36,51)(H,37,44,47)(H,38,45,48)
InChIKeyQPRMZOAFBVJXSC-UHFFFAOYSA-N
XLogP0.42
TPSA245.68 Ų
H-Bond Donors4
H-Bond Acceptors14
Rotatable Bonds8
Heavy Atoms52
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500710.66
LogP ≤ 50.42
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze [1-[2-[[3-(2,6-dioxopiperidin-3-yl)-2-methyl-4-oxoquinazolin-5-yl]amino]-2-oxoethyl]triazol-4-yl]methyl N-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [1-[2-[[3-(2,6-dioxopiperidin-3-yl)-2-methyl-4-oxoquinazolin-5-yl]amino]-2-oxoethyl]triazol-4-yl]methyl N-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]carbamate?
The IUPAC name of [1-[2-[[3-(2,6-dioxopiperidin-3-yl)-2-methyl-4-oxoquinazolin-5-yl]amino]-2-oxoethyl]triazol-4-yl]methyl N-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]carbamate (CID 151626886) is [1-[2-[[3-(2,6-dioxopiperidin-3-yl)-2-methyl-4-oxoquinazolin-5-yl]amino]-2-oxoethyl]triazol-4-yl]methyl N-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]carbamate.
What is the SMILES notation for [1-[2-[[3-(2,6-dioxopiperidin-3-yl)-2-methyl-4-oxoquinazolin-5-yl]amino]-2-oxoethyl]triazol-4-yl]methyl N-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]carbamate?
The canonical SMILES for [1-[2-[[3-(2,6-dioxopiperidin-3-yl)-2-methyl-4-oxoquinazolin-5-yl]amino]-2-oxoethyl]triazol-4-yl]methyl N-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]carbamate is Cc1nc2cccc(NC(=O)Cn3cc(COC(=O)Nc4cccc5c4CN(C4CCC(=O)NC4=O)C5=O)nn3)c2c(=O)n1C1CCC(=O)NC1=O.
What is the InChIKey of [1-[2-[[3-(2,6-dioxopiperidin-3-yl)-2-methyl-4-oxoquinazolin-5-yl]amino]-2-oxoethyl]triazol-4-yl]methyl N-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]carbamate?
The InChIKey is QPRMZOAFBVJXSC-UHFFFAOYSA-N. The full InChI is InChI=1S/C33H30N10O9/c1-16-34-21-6-3-7-22(28(21)32(50)43(16)24-9-11-26(45)38-30(24)48)35-27(46)14-41-12-17(39-40-41)15-52-33(51)36-20-5-2-4-18-19(20)13-42(31(18)49)23-8-10-25(44)37-29(23)47/h2-7,12,23-24H,8-11,13-15H2,1H3,(H,35,46)(H,36,51)(H,37,44,47)(H,38,45,48).
What are the key properties of [1-[2-[[3-(2,6-dioxopiperidin-3-yl)-2-methyl-4-oxoquinazolin-5-yl]amino]-2-oxoethyl]triazol-4-yl]methyl N-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]carbamate?
[1-[2-[[3-(2,6-dioxopiperidin-3-yl)-2-methyl-4-oxoquinazolin-5-yl]amino]-2-oxoethyl]triazol-4-yl]methyl N-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]carbamate has a molecular weight of 710.66 g/mol, XLogP of 0.42, 8 rotatable bonds, 4 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for [1-[2-[[3-(2,6-dioxopiperidin-3-yl)-2-methyl-4-oxoquinazolin-5-yl]amino]-2-oxoethyl]triazol-4-yl]methyl N-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl]carbamate is sourced from PubChem (CID 151626886), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).